ROADZEN INC (RDZN)

VGG7606H1082 - Common Stock

1.62  -0.6 (-27.03%)

After market: 2.64 +1.02 (+62.96%)

Fundamental Rating

0

Overall RDZN gets a fundamental rating of 0 out of 10. We evaluated RDZN against 277 industry peers in the Software industry. RDZN may be in some trouble as it scores bad on both profitability and health. RDZN is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

In the past year RDZN has reported negative net income.
In the past year RDZN has reported a negative cash flow from operations.

1.2 Ratios

The Return On Assets of RDZN (-92.34%) is worse than 90.22% of its industry peers.
Industry RankSector Rank
ROA -92.34%
ROE N/A
ROIC N/A
ROA(3y)0.09%
ROA(5y)N/A
ROE(3y)0.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

RDZN has a worse Gross Margin (26.19%) than 82.97% of its industry peers.
The Profit Margin and Operating Margin are not available for RDZN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, RDZN has more shares outstanding
Compared to 1 year ago, RDZN has a worse debt to assets ratio.

2.2 Solvency

RDZN has an Altman-Z score of -3.02. This is a bad value and indicates that RDZN is not financially healthy and even has some risk of bankruptcy.
RDZN has a Altman-Z score of -3.02. This is amonst the worse of the industry: RDZN underperforms 82.61% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.02
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

RDZN has a Current Ratio of 0.80. This is a bad value and indicates that RDZN is not financially healthy enough and could expect problems in meeting its short term obligations.
RDZN has a worse Current ratio (0.80) than 83.70% of its industry peers.
RDZN has a Quick Ratio of 0.80. This is a bad value and indicates that RDZN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.80, RDZN is doing worse than 82.97% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.8

0

3. Growth

3.1 Past

RDZN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2352.00%.
EPS 1Y (TTM)-2352%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2333.3%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -87.48% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-5965%
EPS Next 2Y-342.66%
EPS Next 3Y-87.48%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RDZN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RDZN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A cheap valuation may be justified as RDZN's earnings are expected to decrease with -87.48% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-342.66%
EPS Next 3Y-87.48%

0

5. Dividend

5.1 Amount

RDZN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ROADZEN INC

NASDAQ:RDZN (7/1/2024, 7:00:02 PM)

After market: 2.64 +1.02 (+62.96%)

1.62

-0.6 (-27.03%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap110.87M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -92.34%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 26.19%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.8
Quick Ratio 0.8
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-2352%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-5965%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y